Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$28.12 +0.03 (+0.11%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$28.27 +0.15 (+0.53%)
As of 09/5/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. ENOV, CNMD, NVCR, SSII, ESTA, CDRE, BLFS, PLSE, MDXG, and KMTS

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Enovis (ENOV), CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Establishment Labs (ESTA), Cadre (CDRE), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), MiMedx Group (MDXG), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

Semler Scientific (NASDAQ:SMLR) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

Semler Scientific has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.

Semler Scientific has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M7.40$40.90M$2.4311.57
Enovis$2.11B0.87-$825.49M-$14.25-2.25

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 98.5% of Enovis shares are owned by institutional investors. 16.4% of Semler Scientific shares are owned by company insiders. Comparatively, 2.7% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Semler Scientific had 14 more articles in the media than Enovis. MarketBeat recorded 22 mentions for Semler Scientific and 8 mentions for Enovis. Enovis' average media sentiment score of 1.45 beat Semler Scientific's score of 0.27 indicating that Enovis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
2 Very Positive mention(s)
3 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Enovis
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Semler Scientific presently has a consensus price target of $81.75, suggesting a potential upside of 190.72%. Enovis has a consensus price target of $51.00, suggesting a potential upside of 58.90%. Given Semler Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Semler Scientific is more favorable than Enovis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Enovis
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Semler Scientific has a net margin of 86.20% compared to Enovis' net margin of -37.80%. Semler Scientific's return on equity of 43.84% beat Enovis' return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific86.20% 43.84% 32.88%
Enovis -37.80%6.78%3.73%

Summary

Semler Scientific beats Enovis on 12 of the 17 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$415.86M$6.94B$5.79B$9.92B
Dividend YieldN/A1.22%6.71%4.53%
P/E Ratio11.5726.4776.0826.13
Price / Sales7.4045.90460.9379.98
Price / Cash6.2821.9036.9659.04
Price / Book1.134.9911.486.09
Net Income$40.90M$176.38M$3.29B$266.51M
7 Day Performance-5.13%-0.03%1.27%0.45%
1 Month Performance-21.14%4.42%7.94%4.58%
1 Year Performance19.00%10.68%62.93%26.04%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
3.5053 of 5 stars
$28.12
+0.1%
$81.75
+190.7%
+18.9%$415.86M$56.29M11.57120News Coverage
ENOV
Enovis
4.2359 of 5 stars
$30.98
-1.5%
$51.00
+64.6%
-25.6%$1.80B$2.11B-2.177,367Positive News
CNMD
CONMED
4.4508 of 5 stars
$54.35
-2.6%
$59.80
+10.0%
-26.1%$1.73B$1.33B15.403,900News Coverage
Positive News
NVCR
NovoCure
4.2159 of 5 stars
$11.70
-5.9%
$28.79
+146.0%
-32.0%$1.39B$605.22M-7.501,488News Coverage
SSII
SS Innovations International
N/A$6.98
-0.1%
N/AN/A$1.35B$20.65M0.004
ESTA
Establishment Labs
2.6648 of 5 stars
$40.66
-6.8%
$56.50
+39.0%
-8.2%$1.26B$177.42M-13.331,018News Coverage
CDRE
Cadre
3.329 of 5 stars
$30.27
-2.5%
$31.50
+4.0%
-9.2%$1.26B$567.56M32.212,284News Coverage
Positive News
BLFS
BioLife Solutions
2.5889 of 5 stars
$25.65
-1.0%
$31.29
+22.0%
+7.0%$1.24B$82.25M-213.73440Positive News
PLSE
Pulse Biosciences
4.0013 of 5 stars
$16.49
-3.3%
$22.00
+33.4%
-13.6%$1.15B$700K-15.70140News Coverage
Positive News
MDXG
MiMedx Group
3.3972 of 5 stars
$7.08
-3.1%
$12.00
+69.5%
+11.9%$1.08B$348.88M33.72870Positive News
KMTS
Kestra Medical Technologies
1.5901 of 5 stars
$17.72
-4.6%
$27.33
+54.3%
N/A$953.80M$59.81M0.00300News Coverage
Positive News
Lockup Expiration

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners